- Previous Close
167.60 - Open
169.00 - Bid 164.00 x --
- Ask 164.20 x --
- Day's Range
164.00 - 169.00 - 52 Week Range
131.40 - 194.00 - Volume
128,869 - Avg. Volume
73,433 - Market Cap (intraday)
16.024B - Beta (5Y Monthly) 0.20
- PE Ratio (TTM)
41.68 - EPS (TTM)
3.94 - Earnings Date Aug 6, 2024 - Aug 12, 2024
- Forward Dividend & Yield 2.00 (1.22%)
- Ex-Dividend Date Jan 17, 2024
- 1y Target Est
159.30
Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, and medical polyclinics; and the provision of manpower and support services to hospitals and medical centers. It manufactures and distributes pharmaceutical, herbal and cosmetic products, and toiletries. In addition, the company engages in the management and operation of hospitals owned by third parties. Further, it manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was formerly known as Dallah Healthcare Holding Company and changed its name to Dallah Healthcare Company in November 2016. The company was incorporated in 1994 and is based in Riyadh, Saudi Arabia.
www.dallahhealth.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 4004.SR
Performance Overview: 4004.SR
Trailing total returns as of 6/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4004.SR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4004.SR
Valuation Measures
Market Cap
16.02B
Enterprise Value
17.73B
Trailing P/E
41.68
Forward P/E
38.17
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.33
Price/Book (mrq)
4.82
Enterprise Value/Revenue
5.89
Enterprise Value/EBITDA
26.92
Financial Highlights
Profitability and Income Statement
Profit Margin
12.78%
Return on Assets (ttm)
5.25%
Return on Equity (ttm)
11.78%
Revenue (ttm)
3.01B
Net Income Avi to Common (ttm)
384.76M
Diluted EPS (ttm)
3.94
Balance Sheet and Cash Flow
Total Cash (mrq)
213.64M
Total Debt/Equity (mrq)
53.33%
Levered Free Cash Flow (ttm)
147.29M